# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001485003-23-000096
Filing Date
2023-03-02
Accepted
2023-03-02 12:06:39
Documents
20
Period of Report
2023-03-02
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | sesn-20230302.htm iXBRL | 8-K | 71916
2 | EX-3.1 | ex31conformedforedgar-pr.htm | EX-3.1 | 3942
3 | EX-99.1 | ex991sesnspecialmeetingr.htm | EX-99.1 | 17219
7 |  | ex31conformedforedgar-pr001.jpg | GRAPHIC | 188073
8 |  | ex31conformedforedgar-pr002.jpg | GRAPHIC | 41677
9 |  | ex991sesnspecialmeetingr001.jpg | GRAPHIC | 226779
10 |  | ex991sesnspecialmeetingr002.jpg | GRAPHIC | 256993
11 |  | ex991sesnspecialmeetingr003.jpg | GRAPHIC | 318711
12 |  | ex991sesnspecialmeetingr004.jpg | GRAPHIC | 244001
| Complete submission text file | 0001485003-23-000096.txt |  | 2014095

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
4 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | sesn-20230302.xsd | EX-101.SCH | 1902
5 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | sesn-20230302_lab.xml | EX-101.LAB | 25850
6 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | sesn-20230302_pre.xml | EX-101.PRE | 13581
14 | EXTRACTED XBRL INSTANCE DOCUMENT | sesn-20230302_htm.xml | XML | 12671

Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Sesen Bio, Inc. (Filer) CIK: 0001485003 (see all company filings)

EIN.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36296 | Film No.: 23697333
SIC: 2834 Pharmaceutical Preparations